In this interactive panel discussion, oncology experts and a patient with small cell lung cancer (SCLC) discuss recent advances in the use of immunotherapy for SCLC management. Experts present the latest efficacy data supporting the use of immune checkpoint inhibitors and strategies for managing treatment-related adverse events. An experienced patient with SCLC provides his unique perspective on treatment administration, education, and expectations. The panel concludes by addressing the personalized selection of patients with SCLC who may benefit from immunotherapy.
Upon completion of this activity, participants should be better able to:
Chief, Thoracic Oncology
Professor, Department of Hematology and Oncology
Co-Director, Immune Monitoring Facility
The Gloria and Edmund M. Dunn Chair, Thoracic Malignancies
Fox Chase Cancer Center
Philadelphia, PA
Professor and Vice-Chair, Faculty Development
Department of Hematology and Medical Oncology
Chair, Thoracic Malignancies Working Group
Director, Thoracic Oncology
Co-Leader, Discovery & Developmental Therapeutics Program
Winship Cancer Institute
Emory University
Druid Hills, GA
Nurse Practitioner, Thoracic and Head and Neck Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
